Reports

Industry Research Reports

Global Phenotypic Drug Discovery Market Research Report 2025

Global Phenotypic Drug Discovery Market Research Report 2025

Industry: Service & Software

Published Date: 2025-02-20

Pages: 72 Pages

Report ld: 4018828

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global market for Phenotypic Drug Discovery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Phenotypic Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phenotypic Drug Discovery.

The Phenotypic Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Phenotypic Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Phenotypic Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

MARKET SEGMENTATION

By Company

  • Eurofins Discovery
  • Sygnature Discovery
  • PsychoGenics
  • siTOOLs Biotech
  • PhoreMost
  • Charles River
  • MaxWell
  • Arctoris

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Platform
  • Service

Segment by Application

  • Cancer
  • Viral Infection
  • Genetic Disease
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

marn_i1

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 3: Detailed analysis of Phenotypic Drug Discovery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

marn_i1

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

marn_i1

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Phenotypic Drug Discovery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Platform

1.2.3 Service

1.3 Market by Application

1.3.1 Global Phenotypic Drug Discovery Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer

1.3.3 Viral Infection

1.3.4 Genetic Disease

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Global Growth Trends

2.1 Global Phenotypic Drug Discovery Market Perspective (2020-2031)

2.2 Global Phenotypic Drug Discovery Growth Trends by Region

2.2.1 Global Phenotypic Drug Discovery Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Phenotypic Drug Discovery Historic Market Size by Region (2020-2025)

2.2.3 Phenotypic Drug Discovery Forecasted Market Size by Region (2026-2031)

2.3 Phenotypic Drug Discovery Market Dynamics

2.3.1 Phenotypic Drug Discovery Industry Trends

2.3.2 Phenotypic Drug Discovery Market Drivers

2.3.3 Phenotypic Drug Discovery Market Challenges

2.3.4 Phenotypic Drug Discovery Market Restraints

muLu

3 Competition Landscape by Key Players

3.1 Global Top Phenotypic Drug Discovery Players by Revenue

3.1.1 Global Top Phenotypic Drug Discovery Players by Revenue (2020-2025)

3.1.2 Global Phenotypic Drug Discovery Revenue Market Share by Players (2020-2025)

3.2 Global Phenotypic Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Phenotypic Drug Discovery Revenue

3.4 Global Phenotypic Drug Discovery Market Concentration Ratio

3.4.1 Global Phenotypic Drug Discovery Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Phenotypic Drug Discovery Revenue in 2024

3.5 Global Key Players of Phenotypic Drug Discovery Head office and Area Served

3.6 Global Key Players of Phenotypic Drug Discovery, Product and Application

3.7 Global Key Players of Phenotypic Drug Discovery, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

muLu

4 Phenotypic Drug Discovery Breakdown Data by Type

4.1 Global Phenotypic Drug Discovery Historic Market Size by Type (2020-2025)

4.2 Global Phenotypic Drug Discovery Forecasted Market Size by Type (2026-2031)

muLu

5 Phenotypic Drug Discovery Breakdown Data by Application

5.1 Global Phenotypic Drug Discovery Historic Market Size by Application (2020-2025)

5.2 Global Phenotypic Drug Discovery Forecasted Market Size by Application (2026-2031)

muLu

6 North America

6.1 North America Phenotypic Drug Discovery Market Size (2020-2031)

6.2 North America Phenotypic Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Phenotypic Drug Discovery Market Size by Country (2020-2025)

6.4 North America Phenotypic Drug Discovery Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

muLu

7 Europe

7.1 Europe Phenotypic Drug Discovery Market Size (2020-2031)

7.2 Europe Phenotypic Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Phenotypic Drug Discovery Market Size by Country (2020-2025)

7.4 Europe Phenotypic Drug Discovery Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

muLu

8 Asia-Pacific

8.1 Asia-Pacific Phenotypic Drug Discovery Market Size (2020-2031)

8.2 Asia-Pacific Phenotypic Drug Discovery Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Phenotypic Drug Discovery Market Size by Region (2020-2025)

8.4 Asia-Pacific Phenotypic Drug Discovery Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

muLu

9 Latin America

9.1 Latin America Phenotypic Drug Discovery Market Size (2020-2031)

9.2 Latin America Phenotypic Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Phenotypic Drug Discovery Market Size by Country (2020-2025)

9.4 Latin America Phenotypic Drug Discovery Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

muLu

10 Middle East & Africa

10.1 Middle East & Africa Phenotypic Drug Discovery Market Size (2020-2031)

10.2 Middle East & Africa Phenotypic Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2020-2025)

10.4 Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

muLu

11 Key Players Profiles

11.1 Eurofins Discovery

11.1.1 Eurofins Discovery Company Details

11.1.2 Eurofins Discovery Business Overview

11.1.3 Eurofins Discovery Phenotypic Drug Discovery Introduction

11.1.4 Eurofins Discovery Revenue in Phenotypic Drug Discovery Business (2020-2025)

11.1.5 Eurofins Discovery Recent Development

11.2 Sygnature Discovery

11.2.1 Sygnature Discovery Company Details

11.2.2 Sygnature Discovery Business Overview

11.2.3 Sygnature Discovery Phenotypic Drug Discovery Introduction

11.2.4 Sygnature Discovery Revenue in Phenotypic Drug Discovery Business (2020-2025)

11.2.5 Sygnature Discovery Recent Development

11.3 PsychoGenics

11.3.1 PsychoGenics Company Details

11.3.2 PsychoGenics Business Overview

11.3.3 PsychoGenics Phenotypic Drug Discovery Introduction

11.3.4 PsychoGenics Revenue in Phenotypic Drug Discovery Business (2020-2025)

11.3.5 PsychoGenics Recent Development

11.4 siTOOLs Biotech

11.4.1 siTOOLs Biotech Company Details

11.4.2 siTOOLs Biotech Business Overview

11.4.3 siTOOLs Biotech Phenotypic Drug Discovery Introduction

11.4.4 siTOOLs Biotech Revenue in Phenotypic Drug Discovery Business (2020-2025)

11.4.5 siTOOLs Biotech Recent Development

11.5 PhoreMost

11.5.1 PhoreMost Company Details

11.5.2 PhoreMost Business Overview

11.5.3 PhoreMost Phenotypic Drug Discovery Introduction

11.5.4 PhoreMost Revenue in Phenotypic Drug Discovery Business (2020-2025)

11.5.5 PhoreMost Recent Development

11.6 Charles River

11.6.1 Charles River Company Details

11.6.2 Charles River Business Overview

11.6.3 Charles River Phenotypic Drug Discovery Introduction

11.6.4 Charles River Revenue in Phenotypic Drug Discovery Business (2020-2025)

11.6.5 Charles River Recent Development

11.7 MaxWell

11.7.1 MaxWell Company Details

11.7.2 MaxWell Business Overview

11.7.3 MaxWell Phenotypic Drug Discovery Introduction

11.7.4 MaxWell Revenue in Phenotypic Drug Discovery Business (2020-2025)

11.7.5 MaxWell Recent Development

11.8 Arctoris

11.8.1 Arctoris Company Details

11.8.2 Arctoris Business Overview

11.8.3 Arctoris Phenotypic Drug Discovery Introduction

11.8.4 Arctoris Revenue in Phenotypic Drug Discovery Business (2020-2025)

11.8.5 Arctoris Recent Development

muLu

12 Analyst's Viewpoints/Conclusions

muLu

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Phenotypic Drug Discovery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Platform
Table 3. Key Players of Service
Table 4. Global Phenotypic Drug Discovery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Phenotypic Drug Discovery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Phenotypic Drug Discovery Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Phenotypic Drug Discovery Market Share by Region (2020-2025)
Table 8. Global Phenotypic Drug Discovery Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Phenotypic Drug Discovery Market Share by Region (2026-2031)
Table 10. Phenotypic Drug Discovery Market Trends
Table 11. Phenotypic Drug Discovery Market Drivers
Table 12. Phenotypic Drug Discovery Market Challenges
Table 13. Phenotypic Drug Discovery Market Restraints
Table 14. Global Phenotypic Drug Discovery Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Phenotypic Drug Discovery Market Share by Players (2020-2025)
Table 16. Global Top Phenotypic Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenotypic Drug Discovery as of 2024)
Table 17. Ranking of Global Top Phenotypic Drug Discovery Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Phenotypic Drug Discovery Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Phenotypic Drug Discovery, Headquarters and Area Served
Table 20. Global Key Players of Phenotypic Drug Discovery, Product and Application
Table 21. Global Key Players of Phenotypic Drug Discovery, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Phenotypic Drug Discovery Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Phenotypic Drug Discovery Revenue Market Share by Type (2020-2025)
Table 25. Global Phenotypic Drug Discovery Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Phenotypic Drug Discovery Revenue Market Share by Type (2026-2031)
Table 27. Global Phenotypic Drug Discovery Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Phenotypic Drug Discovery Revenue Market Share by Application (2020-2025)
Table 29. Global Phenotypic Drug Discovery Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Phenotypic Drug Discovery Revenue Market Share by Application (2026-2031)
Table 31. North America Phenotypic Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Phenotypic Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Phenotypic Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Phenotypic Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Phenotypic Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Phenotypic Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Phenotypic Drug Discovery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Phenotypic Drug Discovery Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Phenotypic Drug Discovery Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Phenotypic Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Phenotypic Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Phenotypic Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Phenotypic Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
Table 46. Eurofins Discovery Company Details
Table 47. Eurofins Discovery Business Overview
Table 48. Eurofins Discovery Phenotypic Drug Discovery Product
Table 49. Eurofins Discovery Revenue in Phenotypic Drug Discovery Business (2020-2025) & (US$ Million)
Table 50. Eurofins Discovery Recent Development
Table 51. Sygnature Discovery Company Details
Table 52. Sygnature Discovery Business Overview
Table 53. Sygnature Discovery Phenotypic Drug Discovery Product
Table 54. Sygnature Discovery Revenue in Phenotypic Drug Discovery Business (2020-2025) & (US$ Million)
Table 55. Sygnature Discovery Recent Development
Table 56. PsychoGenics Company Details
Table 57. PsychoGenics Business Overview
Table 58. PsychoGenics Phenotypic Drug Discovery Product
Table 59. PsychoGenics Revenue in Phenotypic Drug Discovery Business (2020-2025) & (US$ Million)
Table 60. PsychoGenics Recent Development
Table 61. siTOOLs Biotech Company Details
Table 62. siTOOLs Biotech Business Overview
Table 63. siTOOLs Biotech Phenotypic Drug Discovery Product
Table 64. siTOOLs Biotech Revenue in Phenotypic Drug Discovery Business (2020-2025) & (US$ Million)
Table 65. siTOOLs Biotech Recent Development
Table 66. PhoreMost Company Details
Table 67. PhoreMost Business Overview
Table 68. PhoreMost Phenotypic Drug Discovery Product
Table 69. PhoreMost Revenue in Phenotypic Drug Discovery Business (2020-2025) & (US$ Million)
Table 70. PhoreMost Recent Development
Table 71. Charles River Company Details
Table 72. Charles River Business Overview
Table 73. Charles River Phenotypic Drug Discovery Product
Table 74. Charles River Revenue in Phenotypic Drug Discovery Business (2020-2025) & (US$ Million)
Table 75. Charles River Recent Development
Table 76. MaxWell Company Details
Table 77. MaxWell Business Overview
Table 78. MaxWell Phenotypic Drug Discovery Product
Table 79. MaxWell Revenue in Phenotypic Drug Discovery Business (2020-2025) & (US$ Million)
Table 80. MaxWell Recent Development
Table 81. Arctoris Company Details
Table 82. Arctoris Business Overview
Table 83. Arctoris Phenotypic Drug Discovery Product
Table 84. Arctoris Revenue in Phenotypic Drug Discovery Business (2020-2025) & (US$ Million)
Table 85. Arctoris Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
muLu

List of Figures

Figure 1. Phenotypic Drug Discovery Picture
Figure 2. Global Phenotypic Drug Discovery Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Phenotypic Drug Discovery Market Share by Type: 2024 VS 2031
Figure 4. Platform Features
Figure 5. Service Features
Figure 6. Global Phenotypic Drug Discovery Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Phenotypic Drug Discovery Market Share by Application: 2024 VS 2031
Figure 8. Cancer Case Studies
Figure 9. Viral Infection Case Studies
Figure 10. Genetic Disease Case Studies
Figure 11. Others Case Studies
Figure 12. Phenotypic Drug Discovery Report Years Considered
Figure 13. Global Phenotypic Drug Discovery Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Phenotypic Drug Discovery Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Phenotypic Drug Discovery Market Share by Region: 2024 VS 2031
Figure 16. Global Phenotypic Drug Discovery Market Share by Players in 2024
Figure 17. Global Top Phenotypic Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenotypic Drug Discovery as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Phenotypic Drug Discovery Revenue in 2024
Figure 19. North America Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Phenotypic Drug Discovery Market Share by Country (2020-2031)
Figure 21. United States Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Phenotypic Drug Discovery Market Share by Country (2020-2031)
Figure 25. Germany Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Phenotypic Drug Discovery Market Share by Region (2020-2031)
Figure 33. China Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Phenotypic Drug Discovery Market Share by Country (2020-2031)
Figure 41. Mexico Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Phenotypic Drug Discovery Market Share by Country (2020-2031)
Figure 45. Turkey Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Phenotypic Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Eurofins Discovery Revenue Growth Rate in Phenotypic Drug Discovery Business (2020-2025)
Figure 49. Sygnature Discovery Revenue Growth Rate in Phenotypic Drug Discovery Business (2020-2025)
Figure 50. PsychoGenics Revenue Growth Rate in Phenotypic Drug Discovery Business (2020-2025)
Figure 51. siTOOLs Biotech Revenue Growth Rate in Phenotypic Drug Discovery Business (2020-2025)
Figure 52. PhoreMost Revenue Growth Rate in Phenotypic Drug Discovery Business (2020-2025)
Figure 53. Charles River Revenue Growth Rate in Phenotypic Drug Discovery Business (2020-2025)
Figure 54. MaxWell Revenue Growth Rate in Phenotypic Drug Discovery Business (2020-2025)
Figure 55. Arctoris Revenue Growth Rate in Phenotypic Drug Discovery Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Phenotypic Drug Discovery market?zhanKai
The top companies in the global Phenotypic Drug Discovery market are Eurofins Discovery、Sygnature Discovery、PsychoGenics.
den_biaoTiZhungShi

Related Reports

Global Phenotypic Drug Discovery Market Research Report 2025

Industry: Service & Software

Published Date: 2025-02-20

Pages: 72 Pages

Report ld: 4018828

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now